BRCA1 and ovarian carcinoma: Consistent with this idea, we showed that ovarian cancer tissue with a hypermethylated BRCA1 promoter (Figure 2B and C) displayed decreased expression of BRCA1 in comparison with adjacent normal tissue (Figure 2D); Figure 2A shows the location of CpG sites in BRCA1 promoter.